Sedation of Adults with Orally Administered Midazolam in Dentistry – A Retrospective Study
Acta Odontologica Scandinavica · 2024
DOI: 10.2340/aos.v83.41403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Odontologica Scandinavica, 2024. Verfasst von Marika Storskrubb und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic & Oral and Maxillofacial Surgery, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Midazolam, Hypnotics and Sedatives. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The use of midazolam (MZ) has increased in dentistry, but the effect in adults is sparsely studied. The aim of this study was to investigate doses, effects, and side effects of orally administered MZ as a sedative for adults in a dental care organization. Material and methods: A retrospective record review was performed including all adult patients in the dental care organization ≥20 years receiving MZ, identified through a logbook for addictive drugs, during 2020. From patients’ records, the following data were extracted: age, gender, medical history, reason for sedation, performed treatments, doses, effects, and side effects of MZ.
Results
In total, 265 patients on 418 occasions had been sedated, which constituted 2.3 sedations per 1,000 visits and 3.3 sedations per 1,000 treated patients. Mean age was 40.8 years and 67.7% were females. The most common reason for sedation was anxiety. Mean dose in primary dental clinics was 7.9 mg and in specialist clinics, 6.8 mg (p < 0.001). Older patients (>70 years) had lower doses than younger (p < 0.001), while no difference was found between ages 55–70 years and those who were younger. Dental treatment was completed in 91.9% of occasions, and side effects were registered in 2.2%. Successful dental treatment was related to type of treatment performed.
Conclusions
Sedation is rarely used, particularly in primary dental care, and the use varies widely between clinics. MZ administered by dentists seems to be safe and effective. A sedation record should be used to make patient data such as weight and medical conditions available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Plastic & Oral and Maxillofacial Surgery, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Department of Plastic & Oral and Maxillofacial Surgery, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Department of Orofacial Medicine, Public Dental Health, Region Uppsala, Sweden. pia.gabre@uu.…
Zitieren
APA
Storskrubb, M., & Gabre, P. (2024). Sedation of Adults with Orally Administered Midazolam in Dentistry – A Retrospective Study. Acta Odontologica Scandinavica. https://doi.org/10.2340/aos.v83.41403
Vancouver
Storskrubb M, Gabre P. Sedation of Adults with Orally Administered Midazolam in Dentistry – A Retrospective Study. Acta Odontologica Scandinavica. 2024. doi:10.2340/aos.v83.41403
BibTeX
@article{Storskrubb2024,
author = {Storskrubb, Marika and Gabre, Pia},
title = {Sedation of Adults with Orally Administered Midazolam in Dentistry – A Retrospective Study},
journal = {Acta Odontologica Scandinavica},
year = {2024},
doi = {10.2340/aos.v83.41403}
}
EUVIMED